ARNOLD C HANISH
CIK 1233253 · Chief Accounting Officer · last filed 2026-01-02
ARNOLD C HANISH is a Chief Accounting Officer who has filed 49 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $17 of SLRX on Jan 2, 2026. Across all open-market trades the lifetime net is −$331.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.84M
3
49
-$331.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Director | 5,000 | $0.84 | $4.2K | $65.2K | 18 | 2026-01-02 |
| OMER | Director | 17,400 | $8.73 | $152.0K | -$21.1K | 17 | 2025-07-01 |
| LLY | Chief Accounting Officer | 26,201 | $1133.00 | $29.69M | -$375.5K | 14 | 2012-10-30 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-02 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Sell (S) | −27 | -$17 | EDGAR |
| 2025-11-24 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +5,000 | $3.7K | EDGAR |
| 2025-07-01 | OMER | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | OMER | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-27 | OMER | Grant (A) | — | $0 | EDGAR |
| 2023-05-23 | OMER | Mixed | — | -$5.8K | EDGAR |
| 2023-01-05 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | +1,440 | $0 | EDGAR |
| 2022-09-23 | OMER | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | OMER | Grant (A) | — | $0 | EDGAR |